{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:09:03Z","timestamp":1777486143539,"version":"3.51.4"},"reference-count":27,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,7,15]]},"DOI":"10.2169\/internalmedicine.6419-20","type":"journal-article","created":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T22:12:53Z","timestamp":1613340773000},"page":"2307-2313","source":"Crossref","is-referenced-by-count":6,"title":["Progressive Encephalomyelitis with Rigidity and Myoclonus (PERM)-like Symptoms Associated with Anti-ganglionic Acetylcholine Receptor Antibodies"],"prefix":"10.2169","volume":"60","author":[{"given":"Yuki","family":"Kitazaki","sequence":"first","affiliation":[{"name":"Department of Neurology, Fukui-ken Saiseikai Hospital, Japan"},{"name":"Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamichi","family":"Ikawa","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Japan"},{"name":"Department of Advanced Medicine for Community Healthcare, Faculty of Medical Sciences, University of Fukui, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kishitani","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fukui-ken Saiseikai Hospital, Japan"},{"name":"Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Kamisawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fukui-ken Saiseikai Hospital, Japan"},{"name":"Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunya","family":"Nakane","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunari","family":"Nakamoto","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadanori","family":"Hamano","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Japan"},{"name":"Department of Aging and Dementia, Faculty of Medical Sciences, University of Fukui, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Whiteley AM, Swash M, Urich H. Progressive encephalomyelitis with rigidity. Brain 99: 27-42, 1976.","DOI":"10.1093\/brain\/99.1.27"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Thompson PD. The stiff-man syndrome and related disorders. Parkinsonism Relat Disord 8: 147-153, 2001.","DOI":"10.1016\/S1353-8020(01)00029-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Barker RA, Revesz T, Thom M, Marsden CD, Brown P. Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry 65: 633-640, 1998.","DOI":"10.1136\/jnnp.65.5.633"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Carvajal-Gonz\u00e1lez A, Leite MI, Waters P, et al. Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes. Brain 137: 2178-2192, 2014.","DOI":"10.1093\/brain\/awu142"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Turner MR, Irani SR, Leite MI, Nithi K, Vincent A, Ansorge O. Progressive encephalomyelitis with rigidity and myoclonus: glycine and NMDA receptor antibodies. Neurology 77: 439-443, 2011.","DOI":"10.1212\/WNL.0b013e318227b176"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Balint B, Jarius S, Nagel S, et al. Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies. Neurology 82: 1521-1528, 2014.","DOI":"10.1212\/WNL.0000000000000372"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Dineley KT, Pandya AA, Yakel JL. Nicotinic ACh receptors as therapeutic targets in CNS disorders. Trends Pharmacol Sci 36: 96-108, 2015.","DOI":"10.1016\/j.tips.2014.12.002"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Nakane S, Higuchi O, Koga M, et al. Clinical features of autoimmune autonomic ganglionopathy and the detection of subunit-specific autoantibodies to the ganglionic acetylcholine receptor in Japanese patients. PLOS ONE 10: e0118312, 2015.","DOI":"10.1371\/journal.pone.0118312"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Meinck HM, Thompson PD. Stiff man syndrome and related conditions. Mov Disord 17: 853-866, 2002.","DOI":"10.1002\/mds.10279"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ueno S, Miyamoto N, Shimura H, et al. Successful immune moderation treatment for progressive encephalomyelitis with rigidity and myoclonus. Intern Med 54: 219-221, 2015.","DOI":"10.2169\/internalmedicine.54.3760"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Peeters E, Vanacker P, Woodhall M, et al. Supranuclear gaze palsy in glycine receptor antibody-positive progressive encephalomyelitis with rigidity and myoclonus. Mov Disord 27: 1830-1832, 2012.","DOI":"10.1002\/mds.25239"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kraemer M, Berlit P. Progressive encephalomyelitis with rigidity and myoclonus in an 81-year-old patient. Clin Neurol Neurosurg 110: 279-281, 2008.","DOI":"10.1016\/j.clineuro.2007.10.004"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Xu Z, Prasad K, Yeo T. Progressive encephalomyelitis with rigidity and myoclonus in an intellectually disabled patient mimicking neuroleptic malignant syndrome. J Mov Disord 10: 99-101, 2017.","DOI":"10.14802\/jmd.16058"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Degeneffe A, Dagonnier M, D'hondt A, Elosegi JA. A case report of rigidity and recurrent lower limb myoclonus: progressive encephalomyelitis rigidity and myoclonus syndrome, a chameleon. BMC Neurol 18: 173, 2018.","DOI":"10.1186\/s12883-018-1176-3"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Dalakas MC, Fujii M, Li M, McElroy B. The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology 55: 1531-1535, 2000.","DOI":"10.1212\/WNL.55.10.1531"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Strawn JR, Keck PE Jr, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry 164: 870-876, 2007.","DOI":"10.1176\/ajp.2007.164.6.870"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nakane S, Mukaino A, Maeda Y, Higuchi H, Matsuo H, Ando Y. Extra-autonomic manifestations in autoimmune autonomic ganglionopathy: a Japanese survey. J Neurol Neurosurg Psychiatry 88: 367-368, 2017.","DOI":"10.1136\/jnnp-2016-314707"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Baker SK, Morillo C, Vernino S. Autoimmune autonomic ganglionopathy with late-onset encephalopathy. Auton Neurosci 146: 29-32, 2009.","DOI":"10.1016\/j.autneu.2008.10.016"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kuki I, Kawawaki H, Okazaki S, et al. Autoimmune autonomic ganglionopathy in a pediatric patient presenting with acute encephalitis. Brain Dev 38: 605-608, 2016.","DOI":"10.1016\/j.braindev.2015.12.009"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Meinck HM, Thompson PD. Stiff man syndrome and related conditions. Mov Disord 17: 853-866, 2002.","DOI":"10.1002\/mds.10279"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Vernino S, Low PA, Lennon VA. Experimental autoimmune autonomic neuropathy. J Neurophysiol 90: 2053-2059, 2003.","DOI":"10.1152\/jn.00408.2003"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kobayashi S, Yokoyama S, Maruta T, et al. Autoantibody-induced internalization of nicotinic acetylcholine receptor \u03b13 subunit exogenously expressed in human embryonic kidney cells. J Neuroimmunol 257: 102-106, 2013.","DOI":"10.1016\/j.jneuroim.2012.12.010"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Yamakawa M, Mukaino A, Kimura A, et al. Antibodies to the \u03b13 subunit of the ganglionic-type nicotinic acetylcholine receptors in patients with autoimmune encephalitis. J Neuroimmunol 349: 577399, 2020.","DOI":"10.1016\/j.jneuroim.2020.577399"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Galli JR, Clardy SL, Paz Sold\u00e1n MM. Adult-onset opsoclonus-myoclonus syndrome associated with ganglionic acetylcholine receptor autoantibody. Neurologist 21: 99-100, 2016.","DOI":"10.1097\/NRL.0000000000000098"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Nakane S, Mukaino A, Higuchi O, et al. A comprehensive analysis of the clinical characteristics and laboratory features in 179 patients with autoimmune autonomic ganglionopathy. J Autoimmun 108: 102403, 2020.","DOI":"10.1016\/j.jaut.2020.102403"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Matsunaga A, Ikawa M, Yoneda M. Hashimoto encephalopathy. Clin Exp Neuroimmunol 10: 226-233, 2019.","DOI":"10.1111\/cen3.12543"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Yoneda M, Fujii A, Ito A, et al. High prevalence of serum autoantibodies against the amino terminal of \u03b1-enolase in Hashimoto's encephalopathy. J Neuroimmunol 185: 195-200, 2007.","DOI":"10.1016\/j.jneuroim.2007.01.018"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/14\/60_6419-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T04:37:10Z","timestamp":1715143030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/14\/60_6419-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":27,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6419-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,15]]},"article-number":"6419-20"}}